Detailed information for compound 1410469

Basic information

Technical information
  • TDR Targets ID: 1410469
  • Name: 3-(benzoyl)-6,7-dimethoxy-1-[(2-methoxyphenyl )methyl]quinolin-4-one
  • MW: 429.465 | Formula: C26H23NO5
  • H donors: 0 H acceptors: 2 LogP: 4.66 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc2c(cc1OC)n(Cc1ccccc1OC)cc(c2=O)C(=O)c1ccccc1
  • InChi: 1S/C26H23NO5/c1-30-22-12-8-7-11-18(22)15-27-16-20(25(28)17-9-5-4-6-10-17)26(29)19-13-23(31-2)24(32-3)14-21(19)27/h4-14,16H,15H2,1-3H3
  • InChiKey: DZXOSGUYQQXCLH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 6,7-dimethoxy-1-[(2-methoxyphenyl)methyl]-3-(oxo-phenylmethyl)-4-quinolinone
  • 3-(benzoyl)-6,7-dimethoxy-1-(2-methoxybenzyl)-4-quinolone
  • 6,7-dimethoxy-1-[(2-methoxyphenyl)methyl]-3-phenylcarbonyl-quinolin-4-one
  • C567-0706
  • NCGC00110190-01

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Carboxylesterase family protein 0.1071 1 1
Brugia malayi Integrin alpha cytoplasmic region family protein 0.0252 0.1809 0.0803
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.1071 1 1
Echinococcus granulosus acetylcholinesterase 0.1071 1 1
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Echinococcus multilocularis carboxylesterase 5A 0.1071 1 1
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Mycobacterium ulcerans carboxylesterase, LipT 0.0181 0.1093 0.5
Echinococcus multilocularis BC026374 protein (S09 family) 0.0181 0.1093 0.1093
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Echinococcus granulosus carboxylesterase 5A 0.1071 1 1
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0181 0.1093 0.1093
Echinococcus granulosus integrin alpha ps 0.015 0.078 0.078
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Loa Loa (eye worm) hypothetical protein 0.1071 1 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0181 0.1093 0.1093
Echinococcus granulosus neuroligin 0.0181 0.1093 0.1093
Loa Loa (eye worm) hypothetical protein 0.0262 0.1905 0.1905
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0181 0.1093 0.5
Mycobacterium tuberculosis Carboxylesterase LipT 0.0181 0.1093 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0181 0.1093 0.1093
Loa Loa (eye worm) hypothetical protein 0.0252 0.1809 0.1809
Onchocerca volvulus 0.0181 0.1093 0.5
Schistosoma mansoni gliotactin 0.0181 0.1093 0.1093
Echinococcus granulosus integrin alpha 3 0.0256 0.1843 0.1843
Schistosoma mansoni integrin alpha-ps 0.015 0.078 0.078
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0181 0.1093 0.1093
Trichomonas vaginalis spcc417.12 protein, putative 0.0181 0.1093 0.5
Echinococcus granulosus BC026374 protein S09 family 0.0181 0.1093 0.1093
Loa Loa (eye worm) hypothetical protein 0.0184 0.1125 0.1125
Loa Loa (eye worm) acetylcholinesterase 1 0.1071 1 1
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0181 0.1093 0.1093
Schistosoma mansoni integrin alpha 0.0334 0.2622 0.2622
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Echinococcus multilocularis acetylcholinesterase 0.1071 1 1
Echinococcus multilocularis integrin alpha ps 0.015 0.078 0.078
Loa Loa (eye worm) hypothetical protein 0.0078 0.0062 0.0062
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0181 0.1093 0.5
Echinococcus granulosus acetylcholinesterase 0.1071 1 1
Loa Loa (eye worm) carboxylesterase 0.1071 1 1
Loa Loa (eye worm) carboxylesterase 0.0181 0.1093 0.1093
Echinococcus granulosus para nitrobenzyl esterase 0.0181 0.1093 0.1093
Onchocerca volvulus 0.0181 0.1093 0.5
Schistosoma mansoni neuroligin 3 (S09 family) 0.0181 0.1093 0.1093
Brugia malayi Integrin alpha pat-2 precursor 0.0334 0.2622 0.1717
Echinococcus multilocularis integrin alpha 3 0.0256 0.1843 0.1843
Loa Loa (eye worm) hypothetical protein 0.0181 0.1093 0.1093
Echinococcus multilocularis acetylcholinesterase 0.1071 1 1
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0181 0.1093 0.5
Onchocerca volvulus 0.0181 0.1093 0.5
Echinococcus multilocularis integrin alpha ps 0.015 0.078 0.078
Schistosoma mansoni BC026374 protein (S09 family) 0.0181 0.1093 0.1093
Schistosoma mansoni integrin alpha-ps 0.0078 0.0062 0.0062
Echinococcus multilocularis para nitrobenzyl esterase 0.0181 0.1093 0.1093
Loa Loa (eye worm) integrin alpha pat-2 0.0514 0.4431 0.4431
Loa Loa (eye worm) hypothetical protein 0.1071 1 1
Onchocerca volvulus 0.0181 0.1093 0.5
Schistosoma mansoni acetylcholinesterase 0.0181 0.1093 0.1093
Loa Loa (eye worm) carboxylesterase 0.0181 0.1093 0.1093
Onchocerca volvulus 0.0181 0.1093 0.5
Echinococcus multilocularis neuroligin 0.0181 0.1093 0.1093

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 10 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (binding) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] ChEMBL. No reference
Potency (binding) = 25.1189 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 28.1838 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) = 31.6228 um PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] ChEMBL. No reference
Potency (functional) 125.8925 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.